Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sandler

Showing results (61-70 of 321) with videos related to

Pageof 33
Sort By:
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 1, 1992
Use of external memory aids with a head-injured patientA B Sandler, J L Harris
Oncology (Williston Park, N.Y.)|January 24, 2006
First-line treatment for advanced non-small-cell lung cancerJanessa J Laskin, Alan B Sandler
The Oncologist|June 5, 2004
Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab?Roy S Herbst, Alan B Sandler
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancerJanessa J Laskin, Alan B Sandler
Cancer Investigation|October 1, 2005
State of the art in therapy for non-small cell lung cancerJanessa J Laskin, Alan B Sandler
Current Oncology Reports|May 16, 2013
EGFR tyrosine kinase inhibitors: difference in efficacy and resistanceKyle W Robinson, Alan B Sandler
Medical Hypotheses|September 1, 1983
The sparing interaction of bone mass determinants: a hypothesis with implications for osteoporosisR B Sandler, R E LaPorte
Journal of the American Geriatrics Society|March 1, 1981
Quantitative bone assessments: applications and expectationsR B Sandler, D L Herbert
Clinical Lung Cancer|January 11, 2005
Overview of the current status of human epidermal growth factor receptor inhibitors in lung cancerRoy S Herbst, Alan B Sandler
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Epidermal growth factor receptor inhibitors in lung cancer therapyJanessa J Laskin, Alan B Sandler
Pageof 33

Showing results (61-70 of 321) with videos related to

Sort By:
Pageof 33
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 1, 1992
Use of external memory aids with a head-injured patientA B Sandler, J L Harris
Oncology (Williston Park, N.Y.)|January 24, 2006
First-line treatment for advanced non-small-cell lung cancerJanessa J Laskin, Alan B Sandler
The Oncologist|June 5, 2004
Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab?Roy S Herbst, Alan B Sandler
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancerJanessa J Laskin, Alan B Sandler
Cancer Investigation|October 1, 2005
State of the art in therapy for non-small cell lung cancerJanessa J Laskin, Alan B Sandler
Current Oncology Reports|May 16, 2013
EGFR tyrosine kinase inhibitors: difference in efficacy and resistanceKyle W Robinson, Alan B Sandler
Medical Hypotheses|September 1, 1983
The sparing interaction of bone mass determinants: a hypothesis with implications for osteoporosisR B Sandler, R E LaPorte
Journal of the American Geriatrics Society|March 1, 1981
Quantitative bone assessments: applications and expectationsR B Sandler, D L Herbert
Clinical Lung Cancer|January 11, 2005
Overview of the current status of human epidermal growth factor receptor inhibitors in lung cancerRoy S Herbst, Alan B Sandler
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Epidermal growth factor receptor inhibitors in lung cancer therapyJanessa J Laskin, Alan B Sandler
Pageof 33